Categories : Oncology
Product Packaging : 28 in HDPE
Product Composition : 12.5mg, 25mg, 37.5mg, 50mg
Sunitinib Capsules are a multi-targeted receptor tyrosine kinase (RTK) inhibitor used in the treatment of renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). It works by blocking tumor growth pathways and angiogenesis, helping to slow or stop cancer progression.
Genliva Wellness LLP is a reliable Sunitinib capsule exporter from India, offering high-quality targeted oncology capsule formulations for export markets. As a pharma contract manufacturer and third party manufacturing company in India, Genliva supports international distributors, oncology hospitals, and pharmaceutical importers with consistent supply of advanced cancer medicines.
Send MessageSunitinib Capsules are a multi-targeted receptor tyrosine kinase (RTK) inhibitor used in the treatment of renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). It works by blocking tumor growth pathways and angiogenesis, helping to slow or stop cancer progression.
Genliva Wellness LLP is a reliable Sunitinib capsule exporter from India, offering high-quality targeted oncology capsule formulations for export markets. As a pharma contract manufacturer and third party manufacturing company in India, Genliva supports international distributors, oncology hospitals, and pharmaceutical importers with consistent supply of advanced cancer medicines.
Sunitinib Capsules are indicated for:
Use in targeted oncology treatment protocols
